These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 339925)

  • 21. Formation of alpha-methyldopamine ("Catecholamphetamine") from p-hydroxyamphetamine by rat brain microsomes.
    Hoffman AR; Sastry BV; Axelrod J
    Pharmacology; 1979; 19(5):256-60. PubMed ID: 538080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolism of tyramine-3H and octopamine-3H by rat brain.
    Breese GR; Chase TN; Kopin IJ
    Biochem Pharmacol; 1969 Apr; 18(4):863-9. PubMed ID: 4389230
    [No Abstract]   [Full Text] [Related]  

  • 23. [Biochemistry of drugs. XXVII. Disposition and metabolism of p-hydroxynorephedrine-3H in rats].
    Ráz K; Smolík S; Vinarová M; Janda J; Franc Z
    Cesk Farm; 1979 Jun; 28(5):193-7. PubMed ID: 509565
    [No Abstract]   [Full Text] [Related]  

  • 24. Urinary excretion of amphetamine and 4'-hydroxyamphetamine by Sprague Dawley and dark Agouti rats.
    Law MY; Moody DE
    Life Sci; 1994; 54(15):1073-9. PubMed ID: 8152328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Release of 3H-alpha-methyl-m-tyramine from rat striatum in vitro.
    Dorris RL
    Eur J Pharmacol; 1976 Jan; 35(1):225-8. PubMed ID: 1253825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of amphetamine and its hydroxylated metabolites in various areas of the rat brain.
    Jori A; Caccia S
    J Pharm Pharmacol; 1974 Sep; 26(9):746-8. PubMed ID: 4155759
    [No Abstract]   [Full Text] [Related]  

  • 27. Selective involvement of cytochrome P450 2D subfamily in in vivo 4-hydroxylation of amphetamine in rat.
    Law MY; Slawson MH; Moody DE
    Drug Metab Dispos; 2000 Mar; 28(3):348-53. PubMed ID: 10681381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood pressure and heart rate responses evoked by p-hydroxyamphetamine and by p-hydroxynorephedrine. I. The relationship between evoked responses and plasma levels of drug.
    Simpson LL
    J Pharmacol Exp Ther; 1979 Oct; 211(1):225-30. PubMed ID: 40013
    [No Abstract]   [Full Text] [Related]  

  • 29. Toxicity of the amphetamine metabolites 4-hydroxyamphetamine and 4-hydroxynorephedrine in human dopaminergic differentiated SH-SY5Y cells.
    Feio-Azevedo R; Costa VM; Ferreira LM; Branco PS; Pereira FC; Bastos ML; Carvalho F; Capela JP
    Toxicol Lett; 2017 Mar; 269():65-76. PubMed ID: 28115274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of (+)-amphetamine, alpha-methyltyrosine, and alpha-methylphenylalanine on the concentrations of m-tyramine and alpha-methyl-m-tyramine in rat striatum.
    Dougan DF; Duffield AM; Duffield PH; Wade DN
    Br J Pharmacol; 1983 Oct; 80(2):309-14. PubMed ID: 6652380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Displacement of brain and heart noradrenaline by p-hydroxynorephedrine after administration of p-hydroxyamphetamine.
    Lewander T
    Acta Pharmacol Toxicol (Copenh); 1971; 29(1):20-32. PubMed ID: 5107804
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative brain levels of phenylpropanolamine and amphetamine in rats.
    Henderson MG; Fuller RW
    Res Commun Chem Pathol Pharmacol; 1992 Feb; 75(2):247-50. PubMed ID: 1570407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of D-amphetamine inhibition of protein synthesis.
    Baliga BS; Zähringer J; Trachtenberg M; Moskowitz MA; Munro HN
    Biochim Biophys Acta; 1976 Aug; 442(2):239-50. PubMed ID: 953008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The fate of amphetamine and norephedrine in the Tamarin monkey compared with man.
    Dring LG; Franklin RB; Williams RT
    West Afr J Pharmacol Drug Res; 1975 Jun; 2(1):26-30. PubMed ID: 1226730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereoselective accumulation of hydroxylated metabolites of amphetamine in rat striatum and hypothalamus.
    Dougan DF; Duffield AM; Duffield PH; Wade DN
    Br J Pharmacol; 1986 May; 88(1):285-90. PubMed ID: 3708221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The rôle of octopamine in tachyphylaxis to tyramine.
    Pöch GR; Kopin IJ
    Biochem Pharmacol; 1966 Feb; 15(2):210-2. PubMed ID: 5329100
    [No Abstract]   [Full Text] [Related]  

  • 37. Quinidine inhibits in vivo metabolism of amphetamine in rats: impact upon correlation between GC/MS and immunoassay findings in rat urine.
    Moody DE; Ruangyuttikarn W; Law MY
    J Anal Toxicol; 1990; 14(5):311-7. PubMed ID: 2263067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary excretion of 4-hydroxyamphetamine and amphetamine in male and female Sprague-Dawley and Dark Agouti rats following multiple doses of amphetamine.
    Law MY; Moody DE
    Toxicol Lett; 2000 Nov; 117(3):139-44. PubMed ID: 11087979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formation of p-hydroxynorephedrine in brain following intraventricular administration of p-hydroxyamphetamine.
    Freeman JJ; Sulser F
    Neuropharmacology; 1974 Dec; 13(12):1187-90. PubMed ID: 4457764
    [No Abstract]   [Full Text] [Related]  

  • 40. Onthe presence of p-hydroxynorephedrine in the rat brain and heart in relation to changes in catecholamine levels after administration of amphetamine.
    Lewander T
    Acta Pharmacol Toxicol (Copenh); 1971; 29(1):3-48. PubMed ID: 5107805
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.